Mike Enzi said...

It is a sign the administration has put itself in the business of picking economic favorites as a result of the tax law.

Now, we talk about price transparency, both Senator Murray and Senator Alexander brought that up.

Providers are sometimes forced to toss expired biomedical products that have been purchased, but not used.

This administration often seems to make tax decisions for political reasons rather than policy reasons.